ImpediMed Limited
IPDQF
$0.0375
$0.017587.50%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 8.23M | 7.90M | 7.61M | 7.22M | 6.77M |
| Total Other Revenue | -- | -27.00K | -54.00K | -27.30K | -500.00 |
| Total Revenue | 8.23M | 7.90M | 7.61M | 7.22M | 6.77M |
| Cost of Revenue | 1.13M | 1.02M | 922.80K | 895.10K | 861.80K |
| Gross Profit | 7.10M | 6.88M | 6.69M | 6.32M | 5.91M |
| SG&A Expenses | 17.17M | 16.87M | 16.65M | 16.96M | 17.16M |
| Depreciation & Amortization | 2.95M | 2.56M | 2.18M | 1.84M | 1.48M |
| Other Operating Expenses | 1.78M | 2.09M | 2.41M | 2.33M | 2.24M |
| Total Operating Expenses | 23.12M | 22.66M | 22.30M | 22.17M | 21.89M |
| Operating Income | -14.90M | -14.76M | -14.69M | -14.95M | -15.12M |
| Income Before Tax | -15.01M | -14.46M | -13.98M | -13.51M | -12.96M |
| Income Tax Expenses | 16.80K | 16.30K | 15.90K | 18.80K | 21.60K |
| Earnings from Continuing Operations | -15.03 | -14.48 | -14.00 | -13.53 | -12.98 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -15.03M | -14.48M | -14.00M | -13.53M | -12.98M |
| EBIT | -14.90M | -14.76M | -14.69M | -14.95M | -15.12M |
| EBITDA | -13.15M | -13.00M | -13.03M | -13.63M | -14.16M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 4.05T | 4.05T | 4.05T | 4.05T | 4.04T |
| Average Diluted Shares Outstanding | 4.05T | 4.05T | 4.05T | 4.05T | 4.04T |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |